Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

PHASE3CompletedINTERVENTIONAL

Enrollment

393

Participants

Timeline

Start Date

May 27, 2005

Primary Completion Date

February 15, 2006

Study Completion Date

February 23, 2006

Conditions

Migraine

Interventions

DRUG

MK0462, rizatriptan benzoate / Duration of Treatment -1day

DRUG

Comparator: placebo / Duration of Treatment - 1 day

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00111722 - Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) | Biotech Hunter | Biotech Hunter